Literature DB >> 2259318

Drug-induced headache.

N T Mathew1.   

Abstract

Headache induced by medications used for nonheadache conditions, and more importantly, headache perpetuated by symptomatic medications used for primary headache disorders are discussed in detail in this article. The clinical features and mechanisms of drug-induced headaches are reviewed. Ergotamine and analgesic rebound phenomena are described. Management strategies for drug-induced headaches are outlined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2259318

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  8 in total

1.  Sumatriptan is not the only analgesic used inappropriately.

Authors:  P J Goadsby
Journal:  BMJ       Date:  1998-10-10

Review 2.  Drug overuse and rebound headache.

Authors:  Stephen D Silberstein; Dongmei Liu
Journal:  Curr Pain Headache Rep       Date:  2002-06

Review 3.  Analgesic rebound headache. How great is the problem and what can be done?

Authors:  S D Silberstein; W B Young
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

4.  The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache.

Authors:  R E Cull; W H Price; A Dunbar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

5.  Practical strategies for treating chronic migraine with medication overuse: case examples and role play demonstrations.

Authors:  Randall E Weeks
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

6.  Medication Overuse Headache.

Authors:  William B. Young
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.598

Review 7.  Should butalbital-containing analgesics be banned? Yes.

Authors:  William B Young; Hua Chiang Siow
Journal:  Curr Pain Headache Rep       Date:  2002-04

8.  Differences in Clinical Features and Disability according to the Frequency of Medication Use in Patients with Chronic Migraine.

Authors:  Gyoung Im Suh; Jeong Wook Park; Hae Eun Shin
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.